Dr. Fisher has led the cancer center, part of Philadelphia-based Temple University Health System, since 2013. He also served as cancer center director and senior associate dean for cancer programs.
“[Dr. Fisher] has demonstrated an extraordinarily prolific career as a distinguished scientist and clinician, and we wish him well as he moves to the next chapter in his life,” said Michael Young, president and CEO of Temple University Health System and Temple University Hospital.
Robert Uzzo, MD, has been appointed interim CEO of the organization while a national search for a permanent CEO is conducted, the news release said.
Jon Chernoff, MD, PhD, will fill the role of cancer center director.
Fox Chase also announced David Wiest, PhD, has been named scientific director of the Research Institute of Fox Chase Cancer Center, effective Dec. 1.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
